Lista de obras - Anna Maria V. Storniolo - Dominio Público Uruguay

A Computational Statistics Approach to Evaluate Blood Biomarkers for Breast Cancer Risk Stratification

artículo científico publicado en 2019

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

artículo científico publicado en 2018

Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue

artículo científico publicado en 2016

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort

artículo científico publicado en 2009

Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast

artículo científico publicado en 2016

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

artículo científico publicado en 2020

Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

artículo científico publicado en 2015

Association of polymorphisms of angiogenesis genes with breast cancer

artículo científico publicado en 2007

Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover

artículo científico publicado en 2015

CYP2D6 genotype and tamoxifen response

artículo científico publicado en 2005

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

artículo científico publicado en 2005

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.

artículo científico publicado en 2013

Circulating sex hormones and terminal duct lobular unit involution of the normal breast

artículo científico publicado en 2014

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

artículo científico publicado en 2011

Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.

artículo científico publicado en 2011

Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy

artículo científico publicado en 2009

Cytochrome P450 Polymorphisms and their Relationship with Premature Ovarian Failure in Premenopausal Women with Breast Cancer Receiving Doxorubicin and Cyclophosphamide ⬇️

artículo científico publicado el 9 de agosto de 2011

Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer

artículo científico publicado en 2016

Estimating breast tissue-specific DNA methylation age using next-generation sequencing data

scientific article published on 12 March 2020

Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy

artículo científico publicado en 2008

Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes

artículo científico publicado en 2008

Free Fatty Acids Rewire Cancer Metabolism in Obesity-Associated Breast Cancer via Estrogen Receptor and mTOR Signaling

artículo científico publicado en 2019

Genetic Ancestry-dependent Differences in Breast Cancer-induced Field Defects in the Tumor-adjacent Normal Breast

scientific article published on 04 February 2019

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

artículo científico publicado en 2013

Metastatic breast cancer patients' expectations and priorities for symptom improvement

artículo científico publicado en 2018

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study

artículo científico publicado en 2016

Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank.

artículo científico publicado en 2014

Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine

artículo científico publicado en 2014

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

artículo científico publicado en 2014

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer

artículo científico publicado en 2016

Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

artículo científico publicado en 2014

Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast

scientific article published on 07 September 2020

Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer

artículo científico publicado en 2012

Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors

artículo científico publicado en 2017

Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

artículo científico publicado en 2007

Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib.

artículo científico publicado en 2016

Quality of life of African American breast cancer survivors: how much do we know?

artículo científico publicado en 2008

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment

scientific article published on 01 July 2006

Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.

artículo científico publicado en 2018

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

artículo científico publicado en 2015

TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer

artículo científico publicado en 2014

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

artículo científico publicado en 2014

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.

artículo científico publicado en 2015

TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer

scientific article published on 29 October 2019

Tissue-specific Co-expression of Long Non-coding and Coding RNAs Associated with Breast Cancer

scientific article published on 06 September 2016

Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.

artículo científico publicado en 2017

Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis

artículo científico publicado en 2020

West Nile Virus Encephalitis in a Patient with Neuroendocrine Carcinoma.

artículo científico publicado en 2016

Whole Genome Amplification of DNA for Genotyping Pharmacogenetics Candidate Genes ⬇️

artículo científico publicado el 30 de marzo de 2012

Lista de obras de Anna Maria V. Storniolo

A Computational Statistics Approach to Evaluate Blood Biomarkers for Breast Cancer Risk Stratification

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort

Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

Association of polymorphisms of angiogenesis genes with breast cancer

Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover

CYP2D6 genotype and tamoxifen response

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.

Circulating sex hormones and terminal duct lobular unit involution of the normal breast

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.

Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy

Cytochrome P450 Polymorphisms and their Relationship with Premature Ovarian Failure in Premenopausal Women with Breast Cancer Receiving Doxorubicin and Cyclophosphamide ⬇️

Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer

Estimating breast tissue-specific DNA methylation age using next-generation sequencing data

Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy

Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes

Free Fatty Acids Rewire Cancer Metabolism in Obesity-Associated Breast Cancer via Estrogen Receptor and mTOR Signaling

Genetic Ancestry-dependent Differences in Breast Cancer-induced Field Defects in the Tumor-adjacent Normal Breast

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

Metastatic breast cancer patients' expectations and priorities for symptom improvement

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study

Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank.

Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer

Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast

Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer

Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors

Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib.

Quality of life of African American breast cancer survivors: how much do we know?

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment

Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.

TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer

Tissue-specific Co-expression of Long Non-coding and Coding RNAs Associated with Breast Cancer

Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.

Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis

West Nile Virus Encephalitis in a Patient with Neuroendocrine Carcinoma.

Whole Genome Amplification of DNA for Genotyping Pharmacogenetics Candidate Genes ⬇️